Premarket Mover: Protalix Biotherapeutics Inc (PLX) Up 3.39%

Protalix Biotherapeutics Inc (PLX) has risen Wednesday morning, with the stock climbing 3.39% in pre-market trading to 1.22. PLX's short-term technical score of 32 indicates that the stock has traded less bullishly over the last month than 68% of stocks on the market. In the Biotechnology industry, which ranks 117 out of 146 industries, the stock ranks higher than 43% of stocks. Protalix Biotherapeutics Inc has risen 6.31% over the past month, closing at $1.09 on July 13. During this period of time, the stock fell as low as $1.05 and as high as $1.14. The company has an average price target of $11.00.

PLX has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on PLX!

See Full PLX Report

Protalix Biotherapeutics Inc has a Long-Term Technical rank of 73. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 27% of the market scoring higher. In the Biotechnology industry which is number 75 by this metric, PLX ranks better than 75% of stocks.

Important Dates for Investors in PLX:

-Protalix Biotherapeutics Inc is set to release earnings on 8/15/2022. Over the last 12 months, the company has reported EPS of $-0.53. -We do not have a set dividend date for Protalix Biotherapeutics Inc at this time. Click Here To Get The Full Report on Protalix Biotherapeutics Inc (PLX)